Shenzhen Holds Global Investment Conference on December 15
SHENZHEN, China--(BUSINESS WIRE)--Shenzhen is about to hold the 2021 Global Investment Promotion Conference to attract more investment from all over...
SHENZHEN, China--(BUSINESS WIRE)--Shenzhen is about to hold the 2021 Global Investment Promotion Conference to attract more investment from all over...
Open Beta Test Available December 18th to 20th Action-Packed Gameplay on Multiple Platforms Including PC and Console TOKYO--(BUSINESS WIRE)--NEXON Co.,...
SHENZHEN, China--(BUSINESS WIRE)--ADO will promote a green and healthy lifestyle through a "40KM range ebike" and help build a new...
? Dr Jai Das and Dr Muhammad Salman selected to receive a Falcon Award for Disease Elimination ? They will...
MUMBAI--(BUSINESS WIRE)--#CAM--India’s leading law firm, Cyril Amarchand Mangaldas (CAM) announced today the opening of its new foreign law practice in...
HONG KONG--(BUSINESS WIRE)--#SOPAwards2022--The Society of Publishers in Asia (SOPA), a not-for-profit organization dedicated to the pursuit of excellence in journalism,...
Michelin co-develops RFID module to improve tire management operations KYOTO, Japan--(BUSINESS WIRE)--Murata Manufacturing Co., Ltd. (TOKYO:6981) (ISIN:JP3914400001) has co-developed a...
GOYANG, South Korea--(BUSINESS WIRE)--#BioPharmaExhibition--KOREA PACK and concurrent event ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week) will be held as...
SINGAPORE--(BUSINESS WIRE)--Confluent, Inc. (NASDAQ: CFLT), the platform for data in motion, and Alibaba Cloud, the digital technology and intelligence backbone...
? Dr Fe Esperanza Espino is one of five winners selected to win a Falcon Award for Disease Elimination ?...
TAIZHOU, China--(BUSINESS WIRE)--Themed “Hehe Culture and A Community of Shared Future for Mankind”, the 2021 Hehe Culture Global Forum was...
BRUKINSA demonstrated superiority in progression-free survival over chemoimmunotherapy as a first-line treatment for patients with chronic lymphocytic leukemia Consistent efficacy...
Oral presentation at ASH 2021 features positive phase 2 data in Japanese patients with relapsed/refractory ATL Orphan Drug Designation granted...
Follow-up results from Phase 2 trial suggested intolerable adverse events leading to discontinuation of previous BTK inhibitor therapy were unlikely...
LITTLETON, Colo.--(BUSINESS WIRE)--Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) is pleased to report that its previously announced...